Phase 2 study to evaluate efficacy and safety of PQR309 in patients with relapsed or refractory lymphoma

Update Il y a 4 ans
Reference: EUCTR2014-005384-33

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the clinical efficacy of PQR309 in patients with relapsed or refractory lymphoma.


Inclusion criteria

  • Relapsed or refractory lymphoma

Links